CERUS CORP (CERS)
Sector: Health Care
Sector: Health Care
CERUS CORP - Executive Compensation
Chief Medical Officer
Executive Compensation
Richard Benjamin, MD, PhD, serves as the Chief Medical Officer at Cerus Corporation, a biomedical products company focused on developing and commercializing innovative blood safety and transfusion medicine technologies. Dr. Benjamin brings a wealth of experience to his role, having dedicated his career to the fields of transfusion medicine and hematology. He earned his medical degree and doctorate from the University of California, San Francisco, and completed his residency in clinical pathology and transfusion medicine at the same institution. Before joining Cerus Corporation, Dr. Benjamin held several prominent positions in the field of transfusion medicine. He served as the Executive Vice President, Chief Medical Officer, and President of the Biomedical Services at the American Red Cross, where he oversaw the organization's blood services and played a crucial role in ensuring the safety and availability of blood products across the United States. Dr. Benjamin's leadership and expertise were instrumental in implementing innovative strategies to enhance blood safety and improve patient outcomes. His contributions to the field have been recognized through numerous awards and honors, including being elected as a Fellow of the American Association of Blood Banks. As the Chief Medical Officer at Cerus Corporation, Dr. Benjamin is responsible for overseeing the company's medical and scientific strategies, as well as leading the development and implementation of clinical programs. His role involves collaborating with cross-functional teams to advance the company's mission of improving patient care through innovative blood safety solutions. Dr. Benjamin's extensive knowledge and experience in transfusion medicine and hematology make him an invaluable asset to Cerus Corporation, as the company continues to develop and commercialize its groundbreaking technologies to address critical challenges in blood safety and transfusion medicine.